Article info
PDFFriday 07 October 2022 from 13:00 to 14:10
PO.8 E- poster session 8: skin manifestations, SLE and infections, fertility and pregnancy, imaging
PO.8.168 The third dose of mRNA COVID 19 vaccine is safe and efficacious for SLE patients receiving belimumab
Citation
PO.8.168 The third dose of mRNA COVID 19 vaccine is safe and efficacious for SLE patients receiving belimumab
Online issue publication
October 13, 2022
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.